Ahead of a World Health Assembly meeting in May, the United Kingdom is circulating a resolution that outlines goals for improving the quality of clinical trials by boosting funding, adding more trial sites, and fully reporting study results.
The move comes amid increased concerns about meeting global health needs in the wake of the Covid-19 pandemic, which spurred a surge of clinical trials, although some did not include enough participants. The plan now is to build a consensus in order to generate enough reliable data that can be used to inform health policies and medical practice, according to people familiar with the matter.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
